Expression of retinoic acid signaling components ADH7 and ALDH1A1 is reduced in aniridia limbal epithelial cells and a siRNA primary cell based aniridia model.
Alcohol Dehydrogenase
/ genetics
Aldehyde Dehydrogenase
/ genetics
Aldehyde Dehydrogenase 1 Family
Aniridia
/ genetics
Blotting, Western
Cell Differentiation
Cells, Cultured
Corneal Diseases
/ genetics
Epithelium, Corneal
/ metabolism
Gene Expression Regulation
/ physiology
High-Throughput Nucleotide Sequencing
Humans
Limbus Corneae
/ metabolism
Models, Biological
PAX6 Transcription Factor
/ physiology
RNA, Messenger
/ genetics
RNA, Small Interfering
/ genetics
Real-Time Polymerase Chain Reaction
Retinal Dehydrogenase
Serine Peptidase Inhibitors, Kazal Type
/ genetics
Signal Transduction
/ physiology
Transfection
Tretinoin
/ metabolism
ADH7
ALDH1A1
Aniridia
Limbal epithelial cell
SPINK7
mRNA sequencing
siRNA
Journal
Experimental eye research
ISSN: 1096-0007
Titre abrégé: Exp Eye Res
Pays: England
ID NLM: 0370707
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
09
05
2018
revised:
29
08
2018
accepted:
03
10
2018
pubmed:
8
10
2018
medline:
16
4
2019
entrez:
8
10
2018
Statut:
ppublish
Résumé
PAX6-related Aniridia is a sight-threatening disease involving progression of secondary glaucoma and aniridia related keratopathy (ARK). Change or loss of limbal epithelial progenitors causes epithelial surface defects. We analyzed the effect of PAX6 on mRNA expression changes with a two-step approach, as follows. First, we sequenced mRNA from limbal epithelial cells isolated from controls and aniridia patients. Second, we confirmed the bioinformatics and literature-based result list for a small interfering RNA (siRNA)-based primary aniridia cell model (PAX6 knockdown). With this approach, we expected that the genes directly influenced by PAX6 would be distinguishable from those affected secondarily by the ARK disease state. Therefore, epithelial cells were isolated from the limbus region of two patients with aniridia and cultured in keratinocyte serum-free medium. Normal control cells were obtained from the limbus region of corneal donors. For the siRNA-based aniridia cell model, cells were transfected with Lipofectamine and 5 nM siRNA against PAX6 or control treatment. All cells were lysed to yield DNA, RNA, and protein. Reduction of PAX6 protein was assessed by western blot. Aniridia and control Poly-A-enriched RNA libraries were subjected to next-generation sequencing. The differential analysis was a combination of quantification with RSEM and differential tests with edgeR. Gene lists were filtered by comparison to NCBI GEO datasets, annotated with DAVID, and manually annotated using a literature search. Based on the resulting filtered gene list, qPCR primers were purchased, and candidate genes (TP63, ABCG2, ADH7, ALDH1A1, PITX1, DKK1, DSG1, KRT12, KRT3, KRT13, SPINK6, SPINK7, CTSV, SERPINB1) were verified by qPCR on the siRNA-based aniridia cell model. We identified genes that might be regulated by PAX6 and showed that SPINK7 mRNA, which codes for a protease inhibitor, is downregulated in patients as well as in our primary aniridia cell model. ALDH1A1 and AHD7 mRNA levels were reduced in limbal epithelial cells of aniridia patients, and both transcripts were downregulated by PAX6 knockdown in our cell model. This siRNA-based aniridia cell model is a valuable tool for confirming identified PAX6-affected genes that might promote ARK pathogenesis. The model recapitulated expression changes for SPINK7, ADH7, and ALDH1A1 that were also observed in patient samples. These results provide evidence that PAX6 might drive corneal epithelial differentiation by direct or indirect control of retinoic acid signaling processes through ADH7 and ALDH1A1.
Identifiants
pubmed: 30292490
pii: S0014-4835(18)30359-2
doi: 10.1016/j.exer.2018.10.002
pii:
doi:
Substances chimiques
PAX6 Transcription Factor
0
PAX6 protein, human
0
RNA, Messenger
0
RNA, Small Interfering
0
SPINK7 protein, human
0
Serine Peptidase Inhibitors, Kazal Type
0
Tretinoin
5688UTC01R
ADH7 protein, human
EC 1.1.1.1
Alcohol Dehydrogenase
EC 1.1.1.1
Aldehyde Dehydrogenase 1 Family
EC 1.2.1
Aldehyde Dehydrogenase
EC 1.2.1.3
ALDH1A1 protein, human
EC 1.2.1.36
Retinal Dehydrogenase
EC 1.2.1.36
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8-17Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.